Skip to main content
. 2019 Mar 25;173(5):446–454. doi: 10.1001/jamapediatrics.2019.0285

Table 1. Participant Demographics and Clinical Measures at Intake.

Demographic , Mean (SD) ITT Cohort (n = 71) Treatment Group (n = 40) Control Group (n = 31) P Value
Age, y 8.38 (2.46) 8.63 (2.52) 8.74 (1.79) .33
Male, No. (%) 63 (89) 37 (92) 16 (89) .26
Diagnosis, No. (%)
ASD (using Diagnostic and Statistical Manual of Mental Disorders [Fifth Edition]) 68 (96) % (38 (95) 30 (97) .72
Asperger (using Diagnostic and Statistical Manual of Mental Disorders [Fourth Edition]) 3 (4) 2 (5) 1 (3) .72
Comorbidity, No. (%)
Comorbid psychological diagnosis 24 (34) 13 (33) 11 (35) .80
Comorbid neurological condition(s), including seizures, traumatic brain injury, or concussion 6 (8) 4 (10) 2 (6) .60
Only diagnosed with an ASD 41 (58) 23 (58) 18 (58) .75
Race/ethnicity, No. (%)
White/European American 25 (35) 13 (33) 12 (39) .59
Black 2 (3) 1 (3) 1 (3) .86
East Asian/Asian American 17 (24) 10 (25) 7 (23) .82
South Asian/Indian Americanb 6 (8) 1 (3) 5 (16) .04a
Middle Eastern/Arab American 1 (1) 0 (0) 1 (3) .26
Native American/Alaskan Native 0 (0) 0 (0) 0 (0)
Hispanic/Latino/Spanish origin 16 (23) 8 (20) 8 (36) .57
Unknown/not listed 12 (17) 9 (23) 3 (10) .16
Concurrent therapy enrollment, No. (%)
Applied behavior analysis 71 (100) 40 (100) 31 (100)
Social skills therapy 34 (46) 18 (24) 16 (52) .59
Special education classes 44 (59) 23 (31) 21 (68) .39
Speech language pathology 58 (78) 31 (42) 27 (87) .31
Occupational therapy 31 (42) 18 (24) 13 (42) .80
Currently enrolled in 2 of the above therapies 65 (92) 36 (90) 24 (77) .15
Currently enrolled in 3 of the above therapies 50 (70) 28 (70) 18 (58) .30
Currently enrolled in 4 of the above therapies 35 (49) 18 (45) 11 (35) .43
Not currently enrolled in therapy 0 (0) 0 (0) 0 (0)
Social Communication Questionnaire 24.14 (5.02) 23.43 (5.13) 25.06 (4.81) .18
Stanford Binet abbreviated IQ, total standard score 77.76 (21.53) 75.70 (20.71) 80.42 (22.61) .36
NEPSY-II Affect Recognition subscale, scaled scorec 6.65 (4.16) 6.34 (3.98) 7.07 (4.29) .49
Emotion Guessing Game scorec 23.65 (11.54) 22.80 (11.52) 24.74 (11.66) .49
Child Behavior Checklistb
Total problems 67.22 (7.36) 65.95 (7.16) 69.04 (7.39) .10
Internalizing problems 63.34 (8.25) 62.76 (8.42) 64.19 (8.09) .50
Externalizing problems 62.08 (8.78) 60.89 (8.46) 63.77 (9.12) .20
Anxiety/depression 61.14 (8.58) 60.65 (8.43) 61.85 (8.90) .59
Withdrawal/depression 66.51 (8.10) 66.62 (7.84) 66.35 (8.63) .90
Somatic complaints 57.84 (7.80) 56.92 (6.64) 59.15 (9.19) .27
Social problems 65.53 (6.44) 64.78 (5.82) 66.58 (7.20) .28
Thought problems 69.37 (8.98) 68.69 (9.25) 70.31 (8.68) .49
Attention problems 71.33 (10.85) 70.59 (10.62) 72.38 (11.30) .52
Rule-breaking behavior 60.23 (7.04) 58.69 (6.12) 62.35 (7.78) .04a
Aggressive behavior 63.30 (9.07) 62.27 (9.31) 64.77 (8.68) .29
Social Responsiveness Scale, intake scorec
Total scorec 80.71 (9.53) 80.68 (8.41) 80.76 (10.98) .98
Social awareness 74.53 (10.00) 75.50 (9.50) 73.28 (10.66) .37
Social cognition 77.22 (9.53) 77.08 (8.19) 77.41 (11.19) .89
Social communication 80.25 (9.97) 80.24 (9.56) 80.28 (10.65) .99
Social motivation 71.94 (11.05) 72.63 (11.20) 71.03 (11.00) .56
Restricted and repetitive behavior 79.55 (11.63) 78.53 (10.71) 80.90 (12.80) .41
Vineland Adaptive Behavioral Scales II, intake score
Adaptive behavior composite score 72.81 (11.80) 71.45 (12.66) 74.63 (10.48) .27
Communication 75.44 (12.38) 73.83 (12.82) 77.60 (11.63) .21
Daily living skills 78.49 (16.08) 76.23 (15.16) 81.50 (17.01) .18
Socializationc 69.46 (15.19) 68.75 (16.63) 70.40 (13.26) .66
Motor skills 86.09 (15.44) 86.40 (15.72) 85.67 (15.31) .85

Abbreviations: ASD, autism spectrum disorder; ITT, intention to treat; NEPSY-II, A Developmental Neuropsychological Assessment, Second Edition.

a

P value was under .05 between cohorts from a 2-tailed t test.

b

Only the number of South Asian/Indian American participants and the Child Behavior Checklist baseline Rule-Breaking Behavior subscale scores were significantly different between cohorts.

c

Primary outcome measure.